Belatacept with time-limited tacrolimus coimmunosuppression modifies the 3-year risk of eplet mismatch in kidney transplantation-Reference-Cited by-同舟云学术

Belatacept with time-limited tacrolimus coimmunosuppression modifies the 3-year risk of eplet mismatch in kidney transplantation

Published:2024-02 Issue:2 Volume:24 Page:260-270
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:American Journal of Transplantation

Author:

Johnson Aileen C.^ORCID,Zhang Joan,Karadkhele Geeta^ORCID,Gragert Loren^ORCID,Hertzberg Vicki^ORCID,Larsen Christian P.^ORCID

Publisher

Elsevier BV

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Reference35 articles.

1. Organ procurement and transplantation network (OPTN) and scientific registry of transplant recipients (SRTR). OPTN/SRTR 2020 Annual Data Report. Accessed April 4, 2022.

2. Long-term survival after kidney transplantation;Hariharan;N Engl J Med,2021

3. Late graft failure after kidney transplantation as the consequence of late versus early events;Gaston;Am J Transplant,2018

4. Risk factors for late kidney allograft failure;Ponticelli;Kidney Int,2002

5. HLA-EMMA: A user-friendly tool to analyse HLA class I and class II compatibility on the amino acid level;Kramer;HLA,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HLA-DR/DQ eplet mismatch predicts de novo donor-specific antibody development in multi-ethnic Southeast Asian kidney transplant recipients on different immunosuppression regimens;Frontiers in Genetics;2024-08-28

2. Implications of MHC-restricted immunopeptidome in transplantation;Frontiers in Immunology;2024-07-05

3. Belatacept‐based immunosuppression does not confer increased risk of BK polyomavirus‐DNAemia relative to tacrolimus‐based immunosuppression;Transplant Infectious Disease;2024-06-30